Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 533 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 800 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 133 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - tablets sublingual - fentanyl as citrate 67 mcg - fentanyl - treatment of breakthrough pain in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - naloxone hydrochloride (as dihydrate) 15 mg; oxycodone hydrochloride 30 mg - oxycodone and naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around the- clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 20 mg - oxycodone - oxycodone - for the relief of moderate severe chronic pain.

Izraēla - angļu - Ministry of Health

rafa laboratories ltd - oxycodone hydrochloride - tablets controlled release - oxycodone hydrochloride 10 mg - oxycodone - oxycodone - for the relief of moderate to severe chronic pain.